Market open · Delayed intraday data · 11:43 AM ET
Last update: Nov 17, 2026, 11:32 AM ET
HCA Healthcare, Inc.
▲ 10.3% on Nov 4, 2026

Why HCA Healthcare, Inc. (HCA) Stock Rose 10.3% on Nov 4, 2026

Researched by BestStocks Market Desk · Published Nov 4, 2026
Prior close
$462.86
Nov 4, 2026 close
$510.70
Change
+$47.84
+10.34%
Rel. volume
2.6×
3.4M shares

What happened

Valuation+10.3%high confidence

HCA Healthcare surged 10.47% to $511.33 following Democrats' decisive midterm election victory, securing control of both the House and Senate. According to the web catalyst and corroborated by investing.com, cnbc.com, and morningstar.com, the rally reflects expectations that a Democratic-led Congress will reverse or delay Medicaid cuts and protect ACA marketplace funding — removing significant regulatory and reimbursement risks for hospital operators. Volume reached 1.7M shares (2.74x the expected intraday average), underscoring broad conviction in the move.

Source: fmp_intraday
What to watch next

HCA earnings on 2027-01-26 (consensus EPS estimate $8.15) and any Congressional healthcare committee hearings or legislative proposals affecting Medicaid reimbursement rates in the coming weeks.

Frequently asked questions

Why did HCA Healthcare, Inc. (HCA) stock rise on Nov 4, 2026?

HCA Healthcare surged 10.47% to $511.33 following Democrats' decisive midterm election victory, securing control of both the House and Senate. According to the web catalyst and corroborated by investing.com, cnbc.com, and morningstar.com, the rally reflects expectations that a Democratic-led Congress will reverse or delay Medicaid cuts and protect ACA marketplace funding — removing significant regulatory and reimbursement risks for hospital operators. Volume reached 1.7M shares (2.74x the expected intraday average), underscoring broad conviction in the move.

How much did HCA stock rise on Nov 4, 2026?

HCA rose 10.3% during the Nov 4, 2026 trading session.

This is an archived analysis of HCA's Nov 4, 2026 session.
See HCA's latest changes →
Educational research tool — not personalized investment advice. Figures reflect the Nov 4, 2026 session as first analyzed.